SomaScan Assay Data for human serum samples
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- JA-NIAID-2083459
- Agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93021P01255 Federal contract award
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health within the Department of Health and Human Services, published a Limited/Sole Source Justification Notice to obtain serum proteomic profiling data from approximately 7,000 human samples collected as part of a clinical trial studying the effects of Remdesivir with and without Interferon Alpha in human disease intervention. The profiling will utilize SomaLogic's proprietary SomaScan Assay platform, as it is the only system capable of conducting the high-throughput aptamer-based proteomics required. An indefinite delivery contract was awarded on September 6, 2021 to an unknown vendor for an unknown value to support the Center for Human Immunology, Autoimmunity, and Inflammation's systems immunology research program through the provision of this proprietary serum proteomic data.
Notice text
Awarded contract 75N93021P01255 to unknown vendor for unknown amount on 2021-09-06.
Attachments
| File | Type | Posted |
|---|---|---|
| Part_13.5_Single_Source_Commercial_Over_SAT.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity